Arcutis Biotherapeutics
ARQT
ARQT
136 hedge funds and large institutions have $684M invested in Arcutis Biotherapeutics in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 68 increasing their positions, 28 reducing their positions, and 29 closing their positions.
Holders
136
Holders Change
-7
Holders Change %
-4.9%
% of All Funds
2.15%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
22
Increased
68
Reduced
28
Closed
29
Calls
$5.06M
Puts
$3.61M
Net Calls
+$1.46M
Net Calls Change
-$1.41M
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
E
151
Ergoteles
New York
| – | -$333K | -30,296 | Closed |
|
|
SI
152
Symmetry Investments
St Helier,
Jersey
| – | -$330K | -30,000 | Closed |
|
153
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| – | -$327K | -30,000 | Closed |
|
|
NRD
154
Nebula Research & Development
New York
| – | -$286K | -25,976 | Closed |
|
155
Two Sigma Advisers
New York
| – | -$176K | -16,000 | Closed |
|
|
PCM
156
Prelude Capital Management
New York
| – | -$161K | -14,648 | Closed |
|
|
DC
157
Diametric Capital
Boston,
Massachusetts
| – | -$161K | -14,644 | Closed |
|
158
D.E. Shaw & Co
New York
| – | -$117K | -10,629 | Closed |
|
|
GC
159
Guggenheim Capital
Chicago,
Illinois
| – | -$116K | -10,531 | Closed |
|
|
JPMPWA
160
J.P. Morgan Private Wealth Advisors
San Francisco,
California
| – | -$111K | -10,058 | Closed |
|
|
WP
161
WealthPLAN Partners
Omaha,
Nebraska
| – | -$5.5K | -500 | Closed |
|
|
ASN
162
Advisory Services Network
Atlanta,
Georgia
| – | -$4.79K | -435 | Closed |
|
|
TWA
163
TCI Wealth Advisors
Tucson,
Arizona
| – | -$4.07K | -370 | Closed |
|